|
Sports Medicine : NSAID Therapy
To avoid the risks of COX-2 inhibitors, our pharmacy
can compound topically applied NSAIDs such as ibuprofen and ketoprofen.
Topical NSAIDs have a safety profile which is superior to oral formulations.
Topical NSAID administration offers the advantage of local, enhanced delivery
to painful sites with a reduced incidence of systemic adverse effects.
Topical preparations can be customized
to contain
a combination of medications to meet the specific
needs of each patient.
Topical NSAIDs for Acute Pain
“Topical non-steroidal anti-inflammatory
drugs have a lower incidence of gastrointestinal adverse effects than the same
drugs when they are taken orally. The low incidence of systemic adverse effects
for topical NSAIDs probably results from the much lower plasma concentration
from similar doses applied topically to those administered orally. Topical
application of ibuprofen resulted in measurable tissue concentrations in deep
tissue compartments, more than enough to inhibit inflammatory enzymes.”1
Topical NSAIDs have not been associated with renal failure.2
1BMJ. 1995 Jul 1;311(6996):22-6
Topical non-steroidal anti-inflammatory drugs and admission to hospital
for upper gastrointestinal bleeding and perforation: a record linkage case-control
study.
Evans JM, McMahon AD, McGilchrist MM, White G, Murray FE, McDevitt
DG, MacDonald TM.
Department of Clinical Pharmacology, Ninewells Hospital and Medical School,
Dundee.
Click
here to access the PubMed abstract of this article.
Free full text is available at http://bmj.bmjjournals.com/cgi/content/ful
The following article concludes: “Topical non-steroidal
anti-inflammatory drugs are effective in relieving pain in acute and chronic
conditions.”
BMJ. 1998 Jan 31;316(7128):333-8
Quantitative systematic review of topically applied non-steroidal
anti-inflammatory drugs.
Moore RA, Tramer MR, Carroll D, Wiffen PJ, McQuay HJ.
University of Oxford, Oxford Radcliffe Hospital, Headington, UK
Click
here to access the PubMed abstract of this article.
Free full text article available at bmj.com:
http://bmj.bmjjournals.com/cgi/content/full/316/7128/333
The following article reports “The systemic concentrations
of ketoprofen have also been found to be 100 fold lower compared to tissue
concentrations below the application site in patients undergoing knee joint
surgery. Topically applied ketoprofen thus provides high local concentration
below the site of application but lower systemic exposure.”
Pharm Res. 1996 Jan;13(1):168-72
Percutaneous absorption of ketoprofen from different anatomical sites
in man.
Shah AK, Wei G, Lanman RC, Bhargava VO, Weir SJ.
Pfizer Inc., Central Research Division, Groton, Connecticut 06340
Click
here to access the PubMed abstract of this article.
|